TrialJournal of the American Society of Nephrology : JASN2017
Bosutinib versus Placebo for Autosomal Dominant Polycystic Kidney Disease.
Vladimir Tesar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this paperpooled itcites it